Automated cell isolation: flexibility meets performance
Sponsor
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Cell therapy starting material varies significantly, presenting challenges in maintaining a standardized and reproducible manufacturing process. With the rise in cell therapies, automating their manufacturing process is crucial. Automation not only reduces costs and time, but can also improve the safe delivery of these therapies to patients by reducing the risk of contaminations, errors, and batch failures. It’s important to find a highly automated solution to manufacture your cell therapy that’s also flexible enough to adapt to your specific starting material and process needs.
In this webinar, we’ll discuss how the MagnetSelect application on the Sefia Select™ system from Cytiva automates cell isolation from a fresh or thawed apheresis until the resuspension of the isolated cells in the medium of your choice.
Attend this webinar for insights into:
- an automated and closed solution to manufacturing cell therapies
- A flexible system with user-editable and lockable parameters
- Obtaining high purities and recoveries for different cell types
SPEAKERS
